Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 10 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immix Biopharma, Inc. | 500,000 | reported | 22 May 2026 | tx 17+2,157,683 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | GRANT_AWARD | Immix Biopharma, Inc. | 500,000 | 0.00 USD | deriv |
| 10 Dec 2025 | PURCHASE | Immix Biopharma, Inc. | 746 | 6.67 USD | |
| 17 Sept 2025 | PURCHASE | Immix Biopharma, Inc. | 2,500 | 2.02 USD | |
| 20 Jun 2025 | GRANT_AWARD | Immix Biopharma, Inc. | 340,000 | 0.00 USD | deriv |
| 18 Jun 2025 | PURCHASE | Immix Biopharma, Inc. | 2,178 | 2.30 USD | first after silence |
| 11 Jun 2024 | GRANT_AWARD | Immix Biopharma, Inc. | 340,000 | 0.00 USD | deriv |
| 07 Jun 2024 | PURCHASE | Immix Biopharma, Inc. | 2,600 | 2.13 USD | |
| 04 Jun 2024 | PURCHASE | Immix Biopharma, Inc. | 3,300 | 1.81 USD | |
| 20 May 2024 | GRANT_AWARD | Immix Biopharma, Inc. | 218,359 | — | |
| 14 May 2024 | PURCHASE | Immix Biopharma, Inc. | 4,300 | 2.25 USD | first after silence |
| 11 Aug 2023 | GRANT_AWARD | Immix Biopharma, Inc. | 193,000 | 0.00 USD | deriv |
| 14 Nov 2022 | PURCHASE | Immix Biopharma, Inc. | 150 | 0.99 USD | anomaly |
| 14 Nov 2022 | PURCHASE | Immix Biopharma, Inc. | 4,050 | 1.02 USD | |
| 14 Nov 2022 | PURCHASE | Immix Biopharma, Inc. | 1,000 | 0.95 USD | anomaly |
| 14 Jul 2022 | GRANT_AWARD | Immix Biopharma, Inc. | 250,000 | 0.00 USD | deriv |
| 20 Dec 2021 | PURCHASE | Immix Biopharma, Inc. | 2,500 | 5.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 18 Jun 2025.